skip to primary navigationskip to content
 

Astex Pharmaceuticals sold for $886m

last modified Apr 23, 2018 12:32 PM
Astex Pharmaceuticals is to be sold to Otsuka Pharmaceutical.

It has been announced that Astex Pharmaceuticals, co-founded by Sir Tom Blundell in 1999, is to be sold to Japanese company Otsuka Pharmaceutical for $886m. Astex has been developing drugs to treat cancer and uses fragment-based drug discovery, a method under continued development also in the Department. See the story on the University news web site.

Author


Jenny Barna

Publication Date


5 September 2013